Eric Butz

Eric Butz is a co-founding partner at Cascadia Drug Development Group and has over two decades of experience as a cellular and systems immunologist. They have contributed to target identification and validation, leading therapeutic development to phase 2 clinical trials, focusing on various immune cell types and modalities. With a history of positions at companies such as Amgen and Immunex, Eric has specialized in immuno-oncology and inflammatory diseases. Additionally, they hold a BA in Chemistry from Carleton College and a PhD in Microbiology from the University of Minnesota-Twin Cities.